Diana Bell

Also affiliated with University of Pittsburgh Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma”.

Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma

European Journal of Cancer(2021)10.1016/j.ejca.2021.09.046

N/A

1.3DataRank · unranked

55 citations

Yoko Takahashi, Mario Turri‐Zanoni, Jacklyn Liu, Nicholas Counsell, Mario Hermsen +95 more

Brd4::Nutm1fusion gene initiates NUT carcinoma in vivo

Life Science Alliance(2024)10.26508/lsa.202402602

N/A

0.466DataRank · unranked

13 citations

Ahmed A. Elnegiry, Chenxiang Luo, Mohammed Amine Bendahou, Liangqi Xie, Diana Bell +6 more

Therapeutic approaches and outcomes in patients with larynx or hypopharynx high‐grade neuroendocrine carcinoma: A single‐center retrospective analysis

Head & Neck(2021)10.1002/hed.26865

N/A

0DataRank · unranked

8 citations

Felippe Lazar Neto, Danice Torman, Eduardo M. Diaz, David I. Rosenthal, Bonnie S. Glisson +3 more

NRG Oncology HN006: Randomized phase II/III trial of sentinel lymph node biopsy versus elective neck dissection for early-stage oral cavity cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps6093

N/A

0DataRank · unranked

11 citations

Pedro A. Torres‐Saavedra, Neal Dunlap, Beth M. Beadle, Steven S. Chang, Rathan M. Subramaniam +13 more

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3351

N/A

0DataRank · unranked

180 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew O. Old +21 more

International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System

Journal of Neurological Surgery Part B Skull Base(2022)10.1055/s-0042-1750178

N/A

0DataRank · unranked

36 citations

Yoko Takahashi, Mario Turri‐Zanoni, Marco Ferrari, Jacklyn Liu, Nicholas Counsell +64 more

NUTM1-rearranged Carcinoma of the Thyroid

The American Journal of Surgical Pathology(2022)10.1097/pas.0000000000001967

N/A

0DataRank · unranked

28 citations

Steven D. Gilday, Michelle Afkhami, Diana Bell, Theresa Bocklage, Pierre Boisselier +14 more

Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology

Journal of Experimental & Clinical Cancer Research(2022)10.1186/s13046-022-02473-4

N/A

0DataRank · unranked

18 citations

Tongxin Xie, Frederico O. Gleber‐Netto, Patrick J. Hunt, Gautam U. Mehta, Diana Bell +10 more

Single-cell immune mapping of adenoid cystic carcinoma (ACC) reveals potential therapeutic targets for the aggressive solid subtype.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6090

N/A

0DataRank · unranked

5 citations

Felippe Lazar Neto, Daniel J. McGrail, Kaiyi Li, Mario L. Marques‐Piubelli, Sammy Ferri‐Borgogno +8 more

SOX17: a highly sensitive and specific marker for ovarian and endometrial carcinomas

Research Square(2022)10.21203/rs.3.rs-1816167/v1

N/A

0DataRank · unranked

0 citations

Jun Yao, Na Niu, Xiaoran Li, Yan Liu, Lei Huo +11 more

Deep learning‐based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia

Cancer Medicine(2023)10.1002/cam4.5478

N/A

0DataRank · unranked

40 citations

Frederico O. Gleber‐Netto, Shidan Wang, Roberta Rayra Martins‐Chaves, Ricardo Santiago Gomez, Nadarajah Vigneswaran +15 more

SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas

Modern Pathology(2023)10.1016/j.modpat.2022.100001

N/A

0DataRank · unranked

24 citations

Jun Yao, Na Niu, Xiaoran Li, Yan Liu, Lei Huo +12 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305.v1

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more

Data from STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous Carcinoma

(2023)10.1158/1078-0432.c.6521108

N/A

0DataRank · unranked

0 citations

Shaohua Peng, Denise M. Woods, Ignacio I. Wistuba, Diana Bell, Adel K. El‐Naggar +3 more

Predictive biomarkers of benefit to axitinib plus avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (R/M ACC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6096

N/A

0DataRank · unranked

0 citations

Daniel J. McGrail, Simon Heeke, Luana Guimarães de Sousa, Kaiyi Li, Diana Bell +8 more

Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer

Cancer Cell(2024)10.1016/j.ccell.2024.05.003

N/A

0DataRank · unranked

36 citations

Abbie S. Ireland, Sarah B. Hawgood, Tony Reyes, Tiffany Ko, Rachelle R. Olsen +7 more

The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function

Thyroid(2024)10.1089/thy.2023.0542

N/A

0DataRank · unranked

17 citations

Huiyan Ma, Tom Z. Liang, Yan Xing, Samuel Chung, Tanya B. Dorff +3 more

Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach

Translational Oncology(2024)10.1016/j.tranon.2024.101943

N/A

0DataRank · unranked

5 citations

Yoko Takahashi, Michelle R. Padget, Javier A. Gomez, Moran Amit, Jared K. Burks +7 more

Axitinib plus avelumab for recurrent/metastatic adenoid cystic carcinoma (R/M ACC): Biomarker analysis of the phase II trial.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.6104

N/A

0DataRank · unranked

0 citations

Daniel J. McGrail, Yoshitsugu Mitani, Simon Heeke, Luana Guimarães de Sousa, Erison Santos +8 more

Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient Prognosis

Modern Pathology(2025)10.1016/j.modpat.2025.100863

N/A

0DataRank · unranked

5 citations

Craig Nichols, Danielle Hutchings, Diana Bell, Abigail I. Wald, Katelyn Smith +50 more

Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell Carcinoma

Cancers(2020)10.3390/cancers12092433

N/A

0DataRank · unranked

27 citations

Kathryn J. Brayer, Yoshitsugu Mitani, Eric Burns, Pulivarthi H. Rao, Diana Bell +6 more

Comparative transcriptomics of salivary basal cell adenoma and adenocarcinoma sustain linear neoplastic evolution and intertumor heterogeneity: classification and biological implications

The Journal of Pathology(2025)10.1002/path.6424

N/A

0DataRank · unranked

0 citations

Haneen Al‐Maghrabi, Tatiana V. Karpinets, Raissa Relator, Lauren Hilder, Irene Y. Chen +6 more

Prospective, longitudinal digital activity monitoring before and after treatment of low-risk oropharyngeal squamous cell carcinoma: A feasibility study.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6578

N/A

0DataRank · unranked

0 citations

Renata Ferrarotto, Faye M. Johnson, Diana Bell, Richard C. Cardoso, Jason M. Johnson +11 more